InsidersTradesSigma
Follow the 셀바이오휴먼텍 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Food & Beverage sector, 셀바이오휴먼텍 has logged 42 insider filings. Market capitalisation: €50.8bn. The latest transaction was filed on 12 June 2026 (Purchase). Among the most active insiders: 이권선. The full history is free.
42
Insider Decl.
n/a
Thresholds
n/a
41 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,185 of 29,062 companies
66.0
score / 100
Value65
Quality67
FCF yld-9.6%
Earn yld16%
EV/EBITDA6.5x
ROE17%
Gross mgn37%
Net mgn17%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 June 2026
Declarations42 total
25 of 42 declarations
Acerca de 셀바이오휴먼텍
Selbio Human Tech es una empresa que opera en el sector alimentario, cotizada en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para la industria alimentaria.